β-blockers: a new role in cancer chemotherapy? (Q34086281)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

editorial

0 references

title

β-blockers: a new role in cancer chemotherapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

Nouara C Sadaoui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Susan K Lutgendorf

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lois M Ramondetta

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

7 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1359-1363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

6 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Impact of beta blockers on epithelial ovarian cancer survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Expression of beta2-adrenergic receptor in oral squamous cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Prevalence of depression in patients with cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143897

Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1517%2F13543784.2013.825250

Beta blockers and breast cancer mortality: a population- based study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1517%2F13543784.2013.825250

Propranolol for severe hemangiomas of infancy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1517%2F13543784.2013.825250

Psychosocial factors and interleukin-6 among women with advanced ovarian cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23919278

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23919278

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1517/13543784.2013.825250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

23919278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23919278%20AND%20SRC:MED&resulttype=core&format=json